Jacob Cogan

5PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsPacific Peoples youth and familyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 28, 2026
Outcomes of extended reduced-dose apixaban versus full-dose apixaban in cancer-associated venous thromboembolism.

|Sep 21, 2022
New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer.

Jacob C Cogan, Rohit R Raghunathan, Melissa P Beauchemin

|Jul 12, 2022
Efficacy of a password-protected, pill-dispensing device with mail return capacity to enhance disposal of unused opioids after cancer surgery.

Jacob C Cogan, Melissa K Accordino, Melissa P Beauchemin

|May 23, 2022
New persistent opioid use among adolescents and young adults with sarcoma.

Melissa P Beauchemin, Rohit R Raghunathan, Melissa K Accordino

|Jun 05, 2021
New and persistent controlled substance use among patients undergoing mastectomy and reconstructive surgery.

Jacob C Cogan, Rohit R Raghunathan, Melissa P Beauchemin

Pageof 1

Frequent Collaborators

2 joint publications

Melissa P Beauchemin

2 joint publications

Dawn L Hershman

1 joint publications

Justine M Kahn

1 joint publications

Melissa K Accordino